Author

Anna Bosse

Observed name: Anna L Bosse

Institution: Berry Consultants, LLC (United States)

Observed institutions: BG University Hospital Bergmannsheil Bochum, Berry Consultants, LLC (United States), Ruhr University Bochum

OpenAlex ID: A5113101547

Thrombectomy for Stroke With Large Infarct on Noncontrast CT

2024 · Rhonda White, Kerry Gembreska, et al. · JAMA · 147

High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure

2024 · RENOVATE Investigators and the BRICNet Authors, Fabiano Francio, et al. · JAMA · 101

Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage

2025 · Adam S. Arthur, Babak S. Jahromi, et al. · JAMA Neurology · 35

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication

2026 · Amrou Sarraj, Götz Thomalla, et al. · The Lancet · 18

Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial

2025 · Kristy K L Coleman, Scott Berry, et al. · The Lancet Neurology · 18

Lebensqualität beim Restless-Legs-Syndrom

2005 · Romana Gerhard, Anna Bosse, et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin · 17

Intraarterial Treatment Versus No Intraarterial Treatment within 24 Hours in Patients with Ischaemic Stroke and Large Infarct on Noncontrast CT (TESLA): A Multicentre, Open-Label, Blinded-Endpoint, Randomised, Controlled, Phase 3 Trial

2023 · Albert J. Yoo, Osama O. Zaidat, et al. · SSRN Electronic Journal · 9

Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction

2026 · Marvin A. Konstam, James E. Udelson, et al. · Journal of the American College of Cardiology · 5

Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA) as first- and second-line therapy in metastatic pancreatic cancer (mPDAC): Results from Precision Promise (PrP) Bayesian platform trial.

2025 · Vincent J. Picozzi, Anna M. Varghese, et al. · Journal of Clinical Oncology · 2

Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy.

2024 · Paul Eliezer Oberstein, Andrea wang-gillam, et al. · Journal of Clinical Oncology · 1

Works count: 10

Citation count: 352

H-index: 7

I10-index: 6